全身热化疗治疗晚期非小细胞肺癌临床研究

 目的 评价全身热疗联合化疗对晚期非小细胞肺癌（NSCLC）的近期疗效及不良反应。方法 实验组24例，其中男性16例，女性8例；初治18例，复治6例；Ⅲb期15例，Ⅳ期9例；初治患者采用全身热疗联合紫杉醇+卡铂方案，复治患者采用全身热疗联合单药多西他赛（商品名：泰索帝）方案，治疗1周期后，再采用同一方案化疗1周期。对照组26例，其中男性17例，女性9例；初治20例，复治6例；Ⅲb期16例，Ⅳ期10例；初治患者采用紫杉醇+卡铂方案，复治患者采用单药泰索帝方案，化疗2周期。3周为一个周期，完成2周期化疗后4周作疗效评价。结果 实验组有效率为58.3 %，对照组有效率为30.8 %；常见毒副反应为胃肠道反应、神经毒性及骨髓抑制，但均可以耐受。结论 全身热疗联合化疗治疗晚期NSCLC具有显著的治疗效果，并且毒副反应可以耐受。

Whole body hyperthermia combined with chemotherapy for the treatment of advanced non-small cell lung cancer

Objective To evaluate the efficacy and the side effects of whole body hyperthermia(WBH) combined with chemotherapy for the treatment of advanced non-small cell lung cancer. Methods 24 pa－tients were included in trial group(16 male and 8 female), 15 patients in Ⅲb stage and 9 patients in Ⅳ stage.6 patients had received chemotherapy before, received 1 course of WBH combined with Docetaxel; 18 cases were previously untreated, received 1 course of WBH combined with Paclitaxel and Carboplatin, then another course chemotherapy in the same time period. 26 patients were included in control group (17 male and 9 fe－male), 16 patients in Ⅲb stage and 10 patients in Ⅳ stage. 6 patients had received chemotherapy before, were treated with Docetaxel at least 2 courses with 3 weeks interval. 20 cases, previously untreated, were treated with Paclitaxel combined with Carboplatin at least 2 courses with 3 weeks interval. Efficacy was evalu－ated 4 weeks after 2 courses of chemotherapy. Results The response rate was 58.3, and 30.8 in control group. The common side effects were gastrointestinal toxicity , nerve toxicity and leucopenia, but these side effects were all mild. Conclusions WBH combined with chemotherapy is an effective regimen for the treat－ment of advanced non-small cell lung cancer with acceptable toxicity.